Archive: 22/02/2013

Ыtudy documents head and neck cancer molecular tumor subtypes

Head and neck squamous cell carcinoma (HNSCC) is the seventh most common form of cancer in the United States, but other than an association with the human papillomavirus, no validated molecular profile of the disease has ...

Feb 22, 2013

0

0

Adding elesclomol to paclitaxel for advanced melanoma studied

(HealthDay)—Lactate dehydrogenase (LDH) levels may be predictive of success in treating chemotherapy-naive patients with advanced melanoma with a combination of elesclomol plus paclitaxel, according to research published ...

Feb 22, 2013

0

0

US probes J&J on recalled hip implant marketing (Update)

(AP)—U.S. prosecutors are investigating Johnson & Johnson's practices in marketing a line of hip replacements recalled in 2010 because many had to be replaced within a few years—part of a string of more than 30 product ...

Feb 22, 2013

Some patients won't see nurses of different race

It's been called one of medicine's "open secrets"—allowing patients to refuse treatment by a doctor or nurse of another race.

Feb 22, 2013

Reprogramming cells to fight diabetes

For years researchers have been searching for a way to treat diabetics by reactivating their insulin-producing beta cells, with limited success. The "reprogramming" of related alpha cells into beta cells may one day offer ...

Feb 22, 2013

0

0

Hands-on cooking education aids docs' nutrition knowledge

(HealthDay)—Continuing education that includes didactic and hands-on cooking sessions improves physicians' self-reported nutrition-related behaviors, according to a research letter published online Feb. 18 in JAMA Internal ...

Feb 22, 2013

0

0

Natalizumab shows promise for teens with multiple sclerosis

(HealthDay)—Natalizumab may be safe in pediatric multiple sclerosis (MS) patients with highly active disease, according to a small study published online Feb. 18 in JAMA Neurology.

Feb 22, 2013

0

0

Study examines botox dose disparity in aesthetic face tx

(HealthDay)—For patients undergoing onabotulinum toxin A injections, the difference in doses given to achieve desired results in the muscles of the upper and lower face results from variable amounts of paralysis needed ...

Feb 22, 2013

0

0

Mental health and substance use disorder benefits expanded

(HealthDay)—In a final rule, which will make purchasing health coverage easier for consumers, mental health and substance use benefits will be expanded to 62 million Americans, according to a report published Feb. 20 by ...

Feb 22, 2013

0

0

Gene therapy may activate stem cells in heart failure patients

(HealthDay)—Delivery of an SDF-1 encoding plasmid (JVS-100) acts a homing signal for stem cells and improves clinical status in patients with symptomatic heart failure due to ischemic cardiomyopathy (IsCM), according to ...

Feb 22, 2013

0

0

page 1 from 5

«
»